DeepMed Research

University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Effects of Oxytocin Nasal Spray on Social Affiliation

Phase 2

Completed

Conditions: Schizophrenia

Interventions: Drug: Placebo
Drug: Oxytocin

First Posted Date: 2008-04-21

Last Posted Date: 2019-09-09

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 27

Registration Number: NCT00663039

Locations: 🇺🇸
Maryland Psychiatric Research Center, Catonsville, Maryland, United States

Water Immersion in Right-Sided Heart Failure: A Pilot Study

Phase 4

Completed

Conditions: Right Sided Cardiac Failure

Interventions: Procedure: Water immersion

First Posted Date: 2008-04-07

Last Posted Date: 2022-03-09

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 13

Registration Number: NCT00654264

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States

Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer

Not Applicable

Completed

Conditions: Pain
Sleep Disorders
Anxiety Disorder
Depression
Breast Cancer
Hot Flashes
Fatigue

Interventions: Procedure: acupuncture therapy
Procedure: sham intervention

First Posted Date: 2008-03-24

Last Posted Date: 2023-05-08

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 51

Registration Number: NCT00641303

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland, United States

The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis

Phase 3

Completed

Conditions: Ulcerative Colitis
Inflammatory Bowel Disease

Interventions: Other: Best Available Care
Other: UC Home Automated Telemanagement

First Posted Date: 2008-02-21

Last Posted Date: 2019-11-13

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 47

Registration Number: NCT00620126

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins Medical Institute, Baltimore, Maryland, United States

Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus

Early Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Placebo
Drug: Dehydroepiandrosterone

First Posted Date: 2008-02-06

Last Posted Date: 2019-09-12

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 50

Registration Number: NCT00607646

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States

Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4

Early Phase 1

Completed

Conditions: Type 2 Diabetes

Interventions: Other: Hyperinsulinemic Hypoglycemic Clamp

First Posted Date: 2007-12-17

Last Posted Date: 2019-09-12

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 20

Registration Number: NCT00574340

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States

Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes

Early Phase 1

Terminated

Conditions: Metabolic Syndrome

Interventions: Drug: Ramipril+HCTZ
Drug: HCTZ-hydrochlorothiazide
Drug: Ramipril

First Posted Date: 2007-12-17

Last Posted Date: 2019-09-12

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 17

Registration Number: NCT00574834

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States

Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2

Early Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Placebo
Drug: Alprazolam

First Posted Date: 2007-12-17

Last Posted Date: 2019-09-12

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 14

Registration Number: NCT00574639

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States

Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia

Phase 2

Completed

Conditions: Cigarette Smoking
Schizophrenia

Interventions: Drug: varenicline
Drug: placebo

First Posted Date: 2007-11-07

Last Posted Date: 2022-03-18

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 16

Registration Number: NCT00554840

The Effects of Rimonabant, on Weight and Metabolic Risk Factors

Phase 2

Terminated

Conditions: Schizophrenia
Schizoaffective Disorder
Obesity
Hypertension
Smoking

Interventions: Drug: Rimonabant
Drug: Placebo

First Posted Date: 2007-10-22

Last Posted Date: 2019-11-04

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 17

Registration Number: NCT00547118

Locations: 🇺🇸
Sheppard Pratt Health System, Baltimore, Maryland, United States
🇺🇸
Baltimore VA Medical Center, Baltimore, Maryland, United States
🇺🇸
Maryland Psychiatric Research Center (MPRC) Outpatient Research Program (ORP); the MPRC Treatment Research Program (TRP), Catonsville, Maryland, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy